-
Article
Open AccessAuthor Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
-
Article
Open AccessImmunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
When breast cancer patients start to exhibit resistance to hormonal therapy or chemotherapy, the mTOR inhibitor everolimus can be considered as an alternative therapeutic agent. Everolimus can deregulate the P...
-
Article
Open AccessA Novel 96well-formatted Micro-gap Plate Enabling Drug Response Profiling on Primary Tumour Samples
Drug-based treatments are the most widely used interventions for cancer management. Personalized drug response profiling remains inherently challenging with low cell count harvested from tumour sample. We pres...
-
Article
The overexpression of Epithelial cell adhesion molecule (EpCAM) in glioma
Epithelial cell adhesion molecule (EpCAM) is overexpressed in various neoplasms as a tumor-associated antigen and absent in natural brain. However, little is known about EpCAM’s expression in gliomas. To inves...